Apatorsen Completed Phase 2 Trials for Metastatic Bladder Cancer / Urinary Tract Neoplasms / Urologic Neoplasms Treatment

Indications	Status	Purpose	Phase
DBCOND0054408 (Metastatic Bladder Cancer) DBCOND0054409 (Urinary Tract Neoplasms) DBCOND0028416 (Urologic Neoplasms)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01454089	A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer	Apatorsen (DB06094) Carboplatin (DB00958) Cisplatin (DB00515) Gemcitabine (DB00441)